Nordic private equity firm EQT has teamed up with the former chairman of generic German drug company Ratiopharm, Claudio Albrecht, to bid for the company in an auction that could value it at €2bn, according to the Financial Times.
In order to view premium content you need to be a Premium Subscriber. You can subscribe now to access premium online content.
Become a Premium SubscriberIf you are already a AltAssets subscriber please log in below.